B7 CM Heme/Onc Exam 2

0.0(0)
studied byStudied by 0 people
0.0(0)
call with kaiCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/753

flashcard set

Earn XP

Description and Tags

Tumor suppressor genes 🤝 me during exam week: doing absolutely nothing.

Last updated 6:05 AM on 1/30/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

754 Terms

1
New cards

•collect and return interstitial fluid, including plasma protein to the blood, and thus help maintain fluid balance

•defend the body against disease by producing lymphocytes

•absorb lipids from the intestine and transport them to the blood

what are the principal functions of the lymphatic system?

2
New cards

thoracic duct

all lymphatics for the rest of the body drain into the:

3
New cards

lymphatic duct

all lymphatics for the right upper quadrant drain into the:

4
New cards

virchow's node

Supraclavicular node enlargement by metastatic carcinoma

5
New cards

chylothorax

presence of chyle in the pleura, caused by disruption or dysfunction in the flow of chyle through the thoracic duct

<p>presence of chyle in the pleura, caused by disruption or dysfunction in the flow of chyle through the thoracic duct</p>
6
New cards

malignancy, benign tumors, lymphatic disorders

nontraumatic causes of chylothorax

7
New cards

iatrogenic from surgery

traumatic causes of chylothorax

8
New cards

chyle

white or pale yellow substance in lymph that contains fatty substances absorbed by the lacteals

9
New cards

dyspnea without chest pain, as chyle does not invoke an inflammatory response

presentation of chylothorax

10
New cards

-thoracentesis with pleural fluid analysis

-milky appearance, predominantly lymphocytes

-high protein, no glucose, pH 7.4-7.8

-high TGs

diagnostic findings of chylothorax

11
New cards

-fragment of tumors

-infected material

what materials are most commonly spread via the lymph vessels to spread malignancy?

12
New cards

malignancy

if pt presents with lymphadenopathy, what should always be on your ddx?

13
New cards

-strep pharyngitis

-cellulitis or inflammatory conditions of the skin (bug bite, tinea, cat scratch disease)

-inguingal adenopathy of STI: chancre, HSV

-EBV

common etiologies of explained/likely explained lymphadenopathy

14
New cards

tender anterior cervical LAD

lymphadenopathy associated with strep pharyngitis

15
New cards

lymphagitis

infection of lymph vessel walls that occurs in some acute pyogenic infections in which the microbes in the lymph draining from the area infect and spread along the walls of lymph vessels

<p>infection of lymph vessel walls that occurs in some acute pyogenic infections in which the microbes in the lymph draining from the area infect and spread along the walls of lymph vessels</p>
16
New cards

bilateral posterior cervical LAD

adenopathy associated with EBV

17
New cards

EBV

what disease?

-rash will develop in 90% who are treated with amoxicillin

18
New cards

Primary HIV infection

What disease?

-cause of explained lymphadenopathy

-mucocutaneous ulceration

-rash (48-72 hours after onset of fever)

19
New cards

CMV

What disease?

-mild form of EBV mono

-Elevated LFTs more common

-cause of explained lymphadenopathy

20
New cards

toxoplasmosis

What disease?

-Fever and LAD without pharyngitis

-No pharyngitis,

-Normal LFTs

-cause of explainable lymphadenopathy

21
New cards

generalized or localized

with an unexplained lymphadenopathy , must determine if it is:

22
New cards

generalized lymphadenopathy

> 2 noncontiguous LN regions without an explanation

23
New cards

CBC, CXR, HIV, (+/- monospot)

initial testing if you find unexplained generalized lymphadeopathy

24
New cards

supraclavicular > neck > axilla > groin

most to least likely nodes of lymphadenoapthy

25
New cards

allopurinol, atenolol, captopril, cephalosporins, gold, hydralizine, imatinib, penicillin, phenytoin, sulfonamides

select drugs that can cause lymphadenopathy

26
New cards

determine if it is likely cancer

-if no, follow up in 3-4 weeks for changes

-if yes, biopsy

work up if you find an unexplainable, localized lymphadenopathy?

27
New cards

-age over 40

-size >2cm

-duration over 1 month

risk factors pointing to malignancy in unexplained localized lymphadenopathy

28
New cards

abnormal

supraclavicular lymphadenopathy is always

29
New cards

malignant than infectious (vice versa if <20 years old)

A mass in the neck of a patient greater than 40 years old is much more likely to be

30
New cards

biopsy (preferably core)

-image according to results of biopsy if malignancy is found

first step in work up of unexplained axillary adenopathy is

31
New cards

NO!! If it ends up being breast cancer, and excisional biopsy decreases the yield of a sentinel lymph node biopsy and may unnecessarily commit the patient to an axillary lymph node dissection.

Should you perform an excisional biopsy to start with unexplained axillary adenopathy?

32
New cards

inguinal lymph nodes

primary lymph drainage of anus and genitalia, and distal 1/3 of vagina is

33
New cards

inguinal adenopathy

lymphadenopathy often palpable in healthy people without cancer

-Often palpable in healthy people without cancer perhaps because chronic trauma and infection is so common in the LE; also common in obese pts

34
New cards

Contrast cross-sectional CT

initial study of choice for adult pts with neck mass

35
New cards

normal: hypoechoic cortex and echoic central hilum

abnormal: centrally hypoechoic, lost its hilum

normal vs abnnonrmal LN on ultrasound

<p>normal vs abnnonrmal LN on ultrasound</p>
36
New cards

•Size (location & context dependent)

•Morphology (loss of hilum)

•Enhancement

•Invasion (aka extracapsular extension)

things to assess on imaging in work up of lymphadenopathy

37
New cards

▪Currently not sufficient for establishing a diagnosis of cancer

disadvantage of liquid biopsy

38
New cards

useful in the following when additional tissue biopsy is not feasible but diagnosis is already established

▪Identifying therapeutic targets

▪Selecting patients at risk of recurrence

▪Monitoring response to therapy

indications for liquid biopsy of lymphadenopathy

39
New cards

-high false negative rate!

-lack of tissue architecture

-limited material

-generally not sufficient info for establishing initial diagnosis

disadvantage of FNA in evaluating lymphadenopathy

40
New cards

core biopsy

what type of biopsy?

•14 to 20 gauge needle

•Typically under image guidance

•Provides enough tissue for special testing and some information on nodal architecture

•Allows for placement of clips/markers into area of interest

41
New cards

more painful, hematomas can form, generally safe tho

disadvantage of core biopsy

42
New cards

•Excisional - entire abnormal LN is removed

•Incisional - part of abnormal LN is removed

what is the difference between excisional and incisional biopsy

43
New cards

•Allows for assessment of nodal architecture

•Preferred biopsy when lymphoma is suspected

advantages of open biopsy

44
New cards

open biopsy

biopsy type that is generally better to avoid if you think you are dealing with a carcinoma

-removes sentinel node, risk of seeding the skin

45
New cards

lymphedema

▪An accumulation of excessive proteins, edema, chronic inflammation, and fibrosis in tissues secondary to the impairment of the lymph vessels.

Chronic condition, generally not cured

46
New cards

▪congenital absense or anomaly of the lymphatic system

pathophysiology of primary lymphedema

47
New cards

obstruction or interruption of lymphatic system

ex: malignancy, infection, trauma, cancer treatment

pathophysiology of secondary lymphedema

48
New cards

-highest risk associated with axillary dissection + axillary radiation

-lowest risk with sentinel biopsy alone

determinant of risk of lymphedema in breast cancer treated pts

49
New cards

•Psychosocial

•Skin infection

•Lymphangiosarcoma: Stewart-Treves syndrome

complications of lymphedema

50
New cards

do NOT overtreat the axilla!

-avoid excisionnal biopsy in initial workup, perform sentinel node biopsy in clinically negative axilla, neoadjuvant therapy for positive axilla

best way to management treatment relatedd lymphedema

51
New cards

-monitoring, elevation, exercist

-compression therapy

-physiotherapy

conservative management of lymphedema

52
New cards

•Lymphatic bypass procedures

•Excision

•Liposuction

surgical management of lymphedema consnists of

53
New cards

•Synthesis of immunoglobulin G (IgG), properdin (an essential component of the alternate pathway of complement activation), and tuftsin (an immunostimulatory tetrapeptide)

immune functions of the spleen

54
New cards

>12 cm across

size definition of splenomegaly

55
New cards

•No symptoms in some cases

•Pain or fullness in the left upper abdomen that may spread to the left shoulder

•Early satiety

•Anemia

•Fatigue

•Frequent infections

•Thrombocytopenia

•Easy bleeding

symptoms associated with an enlarged spleen

56
New cards

ultrasound

best imaging for monitoring size of spleen

57
New cards

•Biopsy is generally not performed due to risk of bleeding

can I biopsy the spleen?

58
New cards

primary

sarcoidosis is considered a ______ cause of splenomegaly

59
New cards

RhoGAM

drug highly associated with splenomegaly

60
New cards

neutrophilia

most common form of leukocytosis

61
New cards

viral (EBV)

most common infectious cause of lymphocytosis

62
New cards

Drugs

Addisons/allergy

Worms

Neoplasia

DAWN

mnemonic to rremember the most common causes of eosinophilia

63
New cards

CML

most common neoplasm causing basophilia

<p>most common neoplasm causing basophilia</p>
64
New cards

-marked increase in neutrophils >50000

-left shift

-severe infection, trauma, bone marrow infiltration

-looks like leukemia

define criteria of a leukemoid reaction

65
New cards

acute myeloid leukemia

bone marrow aspirate

-blasts are large, moderate amount of grayish blue cytoplasm, no distinct nucleoli

<p>bone marrow aspirate</p><p>-blasts are large, moderate amount of grayish blue cytoplasm, no distinct nucleoli</p>
66
New cards

acute lymphoblastic leukemia

-most common childhood malignancy

-most common cause of cancer death in pts under 20

67
New cards

2-5 years old

peak incidence of ALL

68
New cards

down syndrome

genetic syndrome related to ALL

69
New cards

children complaining of bone pain

-fatigue, infections, bleeding, dyspnea, petichiae, mucosal bleeding, fever

most common presenting symptoms of ALL

70
New cards

-CNS penetration---> meningeal signs, CN deficits, AMS

these symptoms are a MAJOR issue with ALL, but not that common

71
New cards

testicular swelling, neurologic findings, mediastinal mass

less common findings associated with ALL

72
New cards

-CBC w/ diff, peripheral smear, bone marrow exam

-lymph node if there is one

lab orders for workup of suspected ALL

73
New cards

acute leukemia

a high level of blasts in peripheral blood smears should make you suspicious for

74
New cards

lymphoblast

-no auer rods, positive staining for TdT

<p>-no auer rods, positive staining for TdT</p>
75
New cards

myeloblast

-cytoplasmic granules, may see suer rods

-increased prominence of nucleoli

<p>-cytoplasmic granules, may see suer rods</p><p>-increased prominence of nucleoli</p>
76
New cards

immunophenotyping (flow cytometry)

DIAGNOSTIC lab for determinging lymphoid or myleoid lineage

77
New cards

•L1 small cells with homogeneous chromatin

•L2 large heterogeneous cells, irregular cytoplasm

•L3 large homogeneous cells, deep blue cytoplasm

what are the 3 subtypes of ALL as defined by FAB

78
New cards

TdT (terminal deoxynucleotidyl transferase)

both B cell and T cell ALL are positive for

79
New cards

B cell ALL

type of ALL that is HLA-DR positive

80
New cards

the term lymphoma is used when the disease is confined to a mass lesion with little or no blood and marrow involvement

when to use the terrm lymphoma over leukemia

81
New cards

lymphoma type ALL

Mass & <25% blasts in marrow it is

82
New cards

leukemia type ALL

No mass & >25% blasts in marrow it is

83
New cards

5 year overall survival > 90%

prognosis of ALL

84
New cards

-older age (>35)

-high initial WBC count

-under one year old

-female

poor prognosis indicators of ALL

85
New cards

1-9

age to have ALL with the best prognosis

86
New cards

hyperploidy>hypoploidy

ploidy associated with most cases of ALL

87
New cards

•t(9;22) encodes BCR-ABL (activates TK activity)

translocation associated with very poor prognosis with ALL

88
New cards

•t(12;21) encodes ETV6-RUNX1 (transcription factors)

translocation associated with a favorable prognosis of ALL

89
New cards

-good prognosis if good response to steroids in one week, <5% blasts by day 8 or 15 with therapy

-<.01% minimal residual disease

describe how the treatment is a prognostic test in ALL

90
New cards

<5% blasts in bone marrow

bone marrow finding indicative of complete remission

91
New cards

•Poor predictor of prognosis due to poor sensitivity and interobserver variability

bone marrow eval a good predictor of prognosis?

92
New cards

leukemic cells present after therapy but not detectable by conventional morphological assessment; must be found by FISH, PCR, flow cytometry, etc

-BEST PREDICTOR OF PROGNOSIS

define what it means to be measurable residual disease positive

93
New cards

minimal residual disease

What is the best test to predict progosis with ALL?

94
New cards

-almost 2 years of 4-5 chemo regimens

-CNS prophylaxis

-allogenic transplantation in reaching the 1st remission

describe the therapy for ALL

95
New cards

in 1st remission

when can allogenic transplantation be considered for treatment of ALL

96
New cards

infertility, secondary malignancies, growth/maturation changes

complications of ALL after complete remission

97
New cards

-induction 4-6 weeks

-post remission consolidation

-maintenance therapy

what are the phases of treatment of ALL?

98
New cards

tyrosine kinase inhibitor (imatinib, dasatinib)

treatment to add in casess of ALL that are philadelphia chromosome positive

99
New cards

CD19

-may be treated with anti-CD19 immunotherapies

CD marker that is present in over 90% of ALL cases

100
New cards

-combo therapies typically consisting of methotrexate and/or cytarbine

-cranial radiationn reserved for highest risk pts

-incorporated into every phase of treatment

prophylactic CNS therapy regimens for ALL